ArticleJournal of advanced research2026

Targeting PLOD2 induces epithelioid differentiation and improves therapeutic response in sarcomatoid renal cell carcinoma.

Xiangyu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.